CaLycia Bioscience is a startup based in the United States, 1 tracked investor.
CaLycia Bioscience is a startup based in the United States. Brouky records 1 investor associated with the company.
CaLycia Bioscience is a Salt Lake City–based biotechnology company developing engineered macrophage cell therapies for central nervous system (CNS) tumors. Their approach uses locally administered, autologous macrophages designed to infiltrate neural tissue, phagocytose tumor cells, and present antigens to stimulate adaptive immunity against glioblastoma and brain metastases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.